Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities (Tables)

v3.23.1
Accrued Expenses and Other Current Liabilities (Tables)
12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Vaxcyte-related accrual under Vaxcyte Supply Agreement

 

$

4,830

 

 

$

2,286

 

CMO-related accrual

 

 

3,900

 

 

 

1,102

 

Clinical trials-related accrual

 

 

2,954

 

 

 

2,264

 

Other

 

 

3,080

 

 

 

2,750

 

Total accrued expenses and other current liabilities

 

$

14,764

 

 

$

8,402